Huili Pharmaceuticals

Huili Biopharma is a leading synthetic biology company based in Shanghai, China, specializing in the sustainable production of high-value chemicals and active pharmaceutical ingredients (APIs). The company leverages a proprietary technology platform that integrates enzyme engineering, metabolic pathway optimization, and advanced fermentation to replace traditional, resource-intensive chemical synthesis with green biological processes. Huili's portfolio includes bio-manufactured intermediates for major pharmaceutical products in the metabolic, cardiovascular, and anti-inflammatory therapeutic areas, as well as nutritional and health ingredients. Since its inception in 2020, the company has secured significant venture capital funding from top-tier investors to scale its R&D and industrial-scale manufacturing capabilities. Huili aims to drive the transition toward environmentally friendly and cost-effective pharmaceutical manufacturing through its innovative bio-catalysis solutions.